Pharma Reviews: Indian Pharma's incentives to do business in US on steady decline

When Sun Pharma chief Dilip Shanghvi says he sees a big opportunity in China, the world's second-largest drug market, it may be indicative of the ...
Read more: Indian Pharma's incentives to do business in US on steady decline